Rethinking aerosol-generating procedures in COVID-19

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Respiratory Medicine

Background:

• The COVID-19 pandemic highlighted challenges in managing patients requiring aerosol-generating procedures.
• High Flow Nasal Cannula (HFNC) and Non Invasive Ventilation (NIV) are essential respiratory support methods.
• Balancing patient care with healthcare worker safety is paramount.

Purpose of the Study:

• To discuss the role of aerosol-generating procedures like HFNC and NIV in COVID-19 patient management.
• To evaluate whether fear of aerosolization alone justifies withholding these treatments.

Main Methods:

• Review of current literature and clinical guidelines.
• Discussion of the risks and benefits of HFNC and NIV in the context of COVID-19.
• Analysis of the impact of aerosolization concerns on therapeutic decisions.

Main Results:

• HFNC and NIV can be safely employed with appropriate precautions.
• Avoiding these procedures due to fear can lead to suboptimal patient outcomes.
• Evidence supports the use of HFNC and NIV when indicated for COVID-19 pneumonia.

Conclusions:

• Aerosol-generating procedures like HFNC and NIV have a defined place in managing COVID-19 pneumonia.
• Fear of aerosolization should not be the sole reason to avoid these beneficial treatments.
• Careful implementation of safety protocols allows for the continued use of essential respiratory support.